KPC Pharmaceuticals Inc banner

KPC Pharmaceuticals Inc
SSE:600422

Watchlist Manager
KPC Pharmaceuticals Inc Logo
KPC Pharmaceuticals Inc
SSE:600422
Watchlist
Price: 12.15 CNY Market Closed
Market Cap: ¥9.2B

Wall Street
Price Targets

Price Targets Summary
KPC Pharmaceuticals Inc

Wall Street analysts forecast KPC Pharmaceuticals Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KPC Pharmaceuticals Inc is 21.78 CNY with a low forecast of 21.55 CNY and a high forecast of 22.43 CNY.

Lowest
Price Target
21.55 CNY
77% Upside
Average
Price Target
21.78 CNY
79% Upside
Highest
Price Target
22.43 CNY
85% Upside
KPC Pharmaceuticals Inc Competitors:
Price Targets

Revenue
Forecast

10% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
10% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 13 years the compound annual growth rate for KPC Pharmaceuticals Inc's revenue is 10%. The projected CAGR for the next 3 years is 6%.

Operating Income
Forecast

14% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
14% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for KPC Pharmaceuticals Inc's operating income is 14%. The projected CAGR for the next 3 years is 13%.

Net Income
Forecast

13% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
13% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

For the last 13 years the compound annual growth rate for KPC Pharmaceuticals Inc's net income is 13%. The projected CAGR for the next 3 years is 9%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KPC Pharmaceuticals Inc's stock price target?
Price Target
21.78 CNY

According to Wall Street analysts, the average 1-year price target for KPC Pharmaceuticals Inc is 21.78 CNY with a low forecast of 21.55 CNY and a high forecast of 22.43 CNY.

What is KPC Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for KPC Pharmaceuticals Inc's revenue is 10%. The projected CAGR for the next 3 years is 6%.

What is KPC Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
13%

For the last 13 years the compound annual growth rate for KPC Pharmaceuticals Inc's operating income is 14%. The projected CAGR for the next 3 years is 13%.

What is KPC Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
9%

For the last 13 years the compound annual growth rate for KPC Pharmaceuticals Inc's net income is 13%. The projected CAGR for the next 3 years is 9%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett